Acrivon Non Current Assets Total from 2010 to 2024
| ACRV Stock | 8.48 0.29 3.31% |
Check Acrivon Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Acrivon main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Acrivon financial statements analysis is a perfect complement when working with Acrivon Therapeutics Valuation or Volatility modules.
Acrivon |
About Acrivon Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Acrivon Therapeutics income statement, its balance sheet, and the statement of cash flows. Acrivon Therapeutics investors use historical funamental indicators, such as Acrivon Therapeutics's Non Current Assets Total, to determine how well the company is positioned to perform in the future. Although Acrivon Therapeutics investors may use each financial statement separately, they are all related. The changes in Acrivon Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Acrivon Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Acrivon Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Acrivon Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Acrivon Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Acrivon Therapeutics' short interest history, or implied volatility extrapolated from Acrivon Therapeutics options trading.
Pair Trading with Acrivon Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acrivon Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Acrivon Stock
| 0.82 | YS | YS Biopharma | PairCorr |
Moving against Acrivon Stock
| 0.87 | VCNX | Vaccinex | PairCorr |
| 0.85 | VCYT | Veracyte | PairCorr |
| 0.85 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.85 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.82 | VERV | Verve Therapeutics Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to Acrivon Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acrivon Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acrivon Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acrivon Therapeutics Common to buy it.
The correlation of Acrivon Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acrivon Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acrivon Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acrivon Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Acrivon Therapeutics Correlation against competitors. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Acrivon Stock analysis
When running Acrivon Therapeutics' price analysis, check to measure Acrivon Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acrivon Therapeutics is operating at the current time. Most of Acrivon Therapeutics' value examination focuses on studying past and present price action to predict the probability of Acrivon Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acrivon Therapeutics' price. Additionally, you may evaluate how the addition of Acrivon Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |
Is Acrivon Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acrivon Therapeutics. If investors know Acrivon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acrivon Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Acrivon Therapeutics is measured differently than its book value, which is the value of Acrivon that is recorded on the company's balance sheet. Investors also form their own opinion of Acrivon Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Acrivon Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acrivon Therapeutics' market value can be influenced by many factors that don't directly affect Acrivon Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acrivon Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Acrivon Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acrivon Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.